Prehospital HMG Co-A Reductase Inhibitor Use and Reduced Mortality in Ruptured Abdominal Aortic Aneurysm

Journal of the American College of Surgeons

Volumn 209, Issue 1, 2009, Pages 41-46

  Feeney, James M ^a,b   Burns, Karyl ^a,b   Staff, Ilene ^a   Bai, Jilin ^b   Rodrigues, Natercia ^b   Fortier, Jill ^b   Jacobs, Lenworth M ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; AGE DISTRIBUTION; AGED; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; EMERGENCY CARE; FEMALE; GENDER; HEART DISEASE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MORBIDITY; MORTALITY; PHYSIOLOGIC AND OPERATIVE SEVERITY SCORE FOR THE ENUMERATION OF MORTALITY AND MORBIDITY SCORE; PRIORITY JOURNAL; RANK SUM TEST; RETROSPECTIVE STUDY; SCORING SYSTEM; STUDENT T TEST; SURVIVOR;

AGED; AORTIC ANEURYSM, ABDOMINAL; AORTIC RUPTURE; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LENGTH OF STAY; MALE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 67349276362     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2009.03.005     Document Type: Article

References (22)

1. Chen C.H., Lee R.P., Wu W.T., et al. Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats. Resuscitation 74 (2007) 166-174
2. Acheampong E., Parveen Z., Mengistu A., et al. Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro. J Virol 81 (2007) 1492-1501
3. Schmidt H., Hennen R., Keller A., et al. Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Int Care Med 32 (2006) 1248-1251
4. Murata T., Kinoshita K., Hori M., et al. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vasc Biol 25 (2005) 2335-2342
5. Efthymiou C.A., Mocanu M.M., and Yellon D.M. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling. J Cardiovasc Pharmacol 45 (2005) 247-252
6. Giusti-Paiva A., Martinez M.R., Felix J.V., et al. Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats. Shock 21 (2004) 271-275
7. Almog Y. Statins, inflammation, and sepsis: hypothesis. Chest 124 (2003) 740-743
8. Laufs U. Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol 58 (2003) 719-731
9. Zager R.A., and Johnson A. Renal cortical cholesterol accumulation is an integral component of the systemic stress response. Kidney Int 60 (2001) 2299-2310
10. Brouet A., Sonveaux P., Dessy C., et al. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circul Rese 89 (2001) 866-873
11. Feron O., Dessy C., Desager J.P., and Balligand J.L. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103 (2001) 113-118
12. Pirillo A., Jacoviello C., Longoni C., et al. Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells. Biochem Biophys Res Comm 231 (1997) 437-441
13. Sparrow C., Burton C., Hernandez M., et al. Independent of plasma cholesterol lowering simvastatin has anti-inflammatory and antiatherosclerotic activities. Arterioscler Thromb Vasc Biol 21 (2001) 115-121
14. Uchiyama T., Atsuta H., Utsugi T., et al. Simvastatin induces heat shock factor 1 in vascular endothelial cells. Atherosclerosis 188 (2006) 265-273
15. Stoll G., and Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37 (2006) 1923-1932
16. Wei C.Y., Huang K.C., Chou Y.H., et al. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappa B activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells. Mol Pharmacol 69 (2006) 960-967
17. Liappis A.P., Kan V.L., Rochester C.G., and Simon G.L. The effect of statins on mortality in patients with bacteremia. Clin Infect Dis 33 (2001) 1352-1357
18. Almog Y., Shefer A., Novack V., et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 110 (2004) 880-885
19. Efron D.T., Sorock G., Haut E.R., Chang D., et al. Preinjury statin use is associated with improved in-hospital survival in elderly trauma patients. J Trauma 64 (2008) 66-73
20. Tambyraja A.L., Lee A.J., Murie J.A., and Chalmers R.T. Prognostic scoring in ruptured abdominal aortic aneurysm: a prospective evaluation. J Vasc Surg 47 (2008) 282-286
21. Copeland G.P., Jones D., and Walters M. POSSUM: a scoring system for surgical audit. Br J Surg 78 (1991) 355-360
22. Shuhaiber J.H., Hankins M., Robless P., and Whitehead S.M. Comparison of POSSUM with P-POSSUM for prediction of mortality in infrarenal abdominal aortic aneurysm repair. Ann Vasc Surg 16 (2002) 736-741